Table 1. Treatment response group and clinical symptoms of patients with obsessive-compulsive disorder.
| A | B | C | |||
|---|---|---|---|---|---|
| (N = 54) | (N = 22) | (N = 17) | total | Pvalue | |
| Sex (M), N (%) | 24 (44.4) | 12 (54.5) | 10 (58.8) | 46 | 0.51 |
| Sex (F), N (%) | 30 (55.6) | 10 (45.5) | 7 (41.2) | 47 | |
| Age, mean (SD) | 33.28 (12.84) | 30.41 (11.33) | 28.41 (9.86) | 31.71(11.98) | 0.3 |
| Onset age, mean (SD) | 25.07 (10.77) | 23.14 (12.17) | 18.00 (10.88) | 23.32(11.26) | 0.079 |
| Duration of illness, mean (SD) | 8.20 (9.29) | 7.27 (6.17) | 10.41 (10.03) | 8.39(8.72) | 0.53 |
| Y-BOCS score | |||||
| Baseline, mean (SD) | 23.57 (4.85) | 25.55 (4.62) | 28.00 (4.30) | 24.85(4.93) | 0.003 |
| After treatment, mean (SD) | 8.28 (3.89) | 11.36 (3.02) | 25.12 (4.82) | 12.08(7.37) | <0.001 |
| P-values are calculated by χ2 and ANOVA. | |||||
| Duration of illness: length from onset of obsessive complusive disorder to start of treatment in Tokushima university hospital. | |||||
| A: Responders to a selective serotonin reuptake inhibitor | |||||
| B: Responders to a selective serotonin reuptake inhibitor with an atypical antipsychotic | |||||
| C: Non-responders to a selective serotonin reuptake inhibitor with an atypical antipsychotic | |||||